Free Trial

Envista (NVST) Competitors

Envista logo
$19.64 -0.17 (-0.86%)
As of 01:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NVST vs. BRBR, SOLV, SNN, PEN, STVN, GKOS, BLCO, NARI, IRTC, and SLNO

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include BellRing Brands (BRBR), Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), iRhythm Technologies (IRTC), and Soleno Therapeutics (SLNO).

Envista vs. Its Competitors

BellRing Brands (NYSE:BRBR) and Envista (NYSE:NVST) are related mid-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

BellRing Brands has higher earnings, but lower revenue than Envista. Envista is trading at a lower price-to-earnings ratio than BellRing Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BellRing Brands$2.19B3.31$246.50M$2.1526.54
Envista$2.51B1.33-$1.12B-$6.53-3.01

BellRing Brands currently has a consensus price target of $76.69, suggesting a potential upside of 34.41%. Envista has a consensus price target of $20.23, suggesting a potential upside of 3.01%. Given BellRing Brands' stronger consensus rating and higher probable upside, equities analysts plainly believe BellRing Brands is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BellRing Brands
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.81
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33

95.0% of BellRing Brands shares are held by institutional investors. 1.1% of BellRing Brands shares are held by company insiders. Comparatively, 1.3% of Envista shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

BellRing Brands has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Envista has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.

In the previous week, BellRing Brands had 19 more articles in the media than Envista. MarketBeat recorded 25 mentions for BellRing Brands and 6 mentions for Envista. Envista's average media sentiment score of 1.10 beat BellRing Brands' score of 0.59 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BellRing Brands
10 Very Positive mention(s)
1 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BellRing Brands has a net margin of 12.82% compared to Envista's net margin of -44.90%. Envista's return on equity of 4.07% beat BellRing Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
BellRing Brands12.82% -133.63% 32.69%
Envista -44.90%4.07%2.25%

Summary

BellRing Brands beats Envista on 11 of the 17 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$3.33B$10.19B$5.56B$20.60B
Dividend YieldN/A2.09%4.23%3.65%
P/E Ratio-3.0116.9728.6127.20
Price / Sales1.3328.48437.4953.52
Price / Cash12.0622.6736.0222.28
Price / Book1.153.608.184.58
Net Income-$1.12B$233.40M$3.23B$995.22M
7 Day Performance-3.58%-2.88%-0.25%-1.09%
1 Month Performance3.44%1.60%5.40%3.25%
1 Year Performance16.52%-19.42%26.35%6.97%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
3.4854 of 5 stars
$19.64
-0.9%
$20.23
+3.0%
+24.2%$3.33B$2.51B-3.0112,300Analyst Revision
BRBR
BellRing Brands
4.2154 of 5 stars
$57.28
-0.5%
$76.69
+33.9%
+9.7%$7.27B$2.00B26.64380News Coverage
SOLV
Solventum
0.7261 of 5 stars
$76.24
-2.9%
$81.50
+6.9%
+52.8%$13.19B$8.25B35.3022,000Analyst Upgrade
SNN
Smith & Nephew SNATS
2.8815 of 5 stars
$29.95
-1.1%
$28.00
-6.5%
+5.9%$13.12B$5.81B13.8717,349
PEN
Penumbra
4.7324 of 5 stars
$248.05
-1.2%
$302.40
+21.9%
+23.4%$9.61B$1.19B234.014,500
STVN
Stevanato Group
N/A€24.23
-1.5%
N/A+21.0%€7.34B€1.19B47.515,521Positive News
GKOS
Glaukos
4.3297 of 5 stars
$101.69
-1.7%
$134.67
+32.4%
-20.2%$5.81B$383.48M-42.91780Analyst Forecast
BLCO
Bausch + Lomb
3.0186 of 5 stars
$13.83
-0.4%
$15.54
+12.4%
-13.4%$4.89B$4.83B-13.4313,500
NARI
Inari Medical
0.2615 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.0132 of 5 stars
$139.22
-2.3%
$138.60
-0.4%
+35.8%$4.44B$591.84M-44.342,000Analyst Forecast
SLNO
Soleno Therapeutics
4.5825 of 5 stars
$85.27
-1.6%
$107.10
+25.6%
+66.5%$4.30BN/A-18.4630

Related Companies and Tools


This page (NYSE:NVST) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners